tetraphenylphosphonium has been researched along with carvedilol in 2 studies
Studies (tetraphenylphosphonium) | Trials (tetraphenylphosphonium) | Recent Studies (post-2010) (tetraphenylphosphonium) | Studies (carvedilol) | Trials (carvedilol) | Recent Studies (post-2010) (carvedilol) |
---|---|---|---|---|---|
438 | 0 | 39 | 2,933 | 680 | 1,052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
Bjork, JA; Froberg, MK; Leino, RL; Moreno, AJ; Oliveira, PJ; Santos, MS; Wallace, KB | 1 |
2 other study(ies) available for tetraphenylphosphonium and carvedilol
Article | Year |
---|---|
Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors.
Topics: 3T3 Cells; Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport, Active; Cell Line; Cell Separation; Cell Survival; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Mice; Protein Binding; Reserpine; Spectrometry, Fluorescence; Substrate Specificity; Time Factors | 2001 |
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity.
Topics: Adrenergic beta-Antagonists; Animals; Antibiotics, Antineoplastic; Antioxidants; Calcium; Carbazoles; Cardiomyopathies; Carvedilol; Cell Surface Extensions; Doxorubicin; Glutathione Peroxidase; Glutathione Reductase; Ion Channels; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Onium Compounds; Organophosphorus Compounds; Oxygen Consumption; Propanolamines; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2004 |